Phathom Pharmaceuticals, Inc. (PHAT)
NASDAQ: PHAT · Real-Time Price · USD
10.67
-0.07 (-0.65%)
At close: Mar 6, 2026, 4:00 PM EST
10.46
-0.21 (-1.97%)
After-hours: Mar 6, 2026, 7:39 PM EST

Phathom Pharmaceuticals Market Cap

Phathom Pharmaceuticals has a market cap or net worth of $840.78 million as of March 6, 2026. Its market cap has increased by 121.95% in one year.

Market Cap
840.78M
Enterprise Value
1.30B
1-Year Change
121.95%
Ranking
Category
Stock Price
$10.67

Market Cap Chart

Since October 25, 2019, Phathom Pharmaceuticals's market cap has increased from $527.13M to $840.78M, an increase of 59.50%. That is a compound annual growth rate of 7.61%.

History

DateMarket Cap% Change
Mar 6, 2026840.78M-28.76%
Dec 31, 20251.18B112.56%
Dec 31, 2024555.22M6.22%
Dec 29, 2023522.72M13.23%
Dec 30, 2022461.63M-22.48%
Dec 31, 2021595.53M-36.35%
Dec 31, 2020 Pro Pro
Dec 31, 2019 Pro Pro

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding
Full Definition

Related Stocks

Company Market Cap
SELLAS Life Sciences Group 899.09M
SpyGlass Pharma 880.25M
Arvinas 877.54M
MannKind 871.92M
Janux Therapeutics 849.82M
KalVista Pharmaceuticals 819.36M
Xencor 818.46M
Omeros 814.65M
Market Cap Rankings